Evidence

Surveillance report 2016 – Spasticity in under 19s: management (2012) NICE guideline CG145

Surveillance decision

Surveillance decision

We will not update the guideline at this time.

Reason for the decision

We found 52 studies through surveillance of this guideline.

This included new evidence on:

  • principles of care

  • physical therapy (physiotherapy and/or occupational therapy)

  • orthoses

  • oral drugs

  • botulinum toxin type A

  • intrathecal baclofen

  • orthopaedic surgery

  • selective dorsal rhizotomy.

None of the new evidence considered in surveillance of this guideline was thought to have an effect on current recommendations.

Other clinical areas

We also found new evidence in areas not covered by the original guideline that was not thought to have an effect on current recommendations. This evidence related to:

  • magnetic stimulation, electrical stimulation, vibration training and shock wave therapy

  • umbilical cord blood cell therapy

  • scoliosis and kyphosis.

Equalities

No equalities issues were identified during the surveillance process.

Overall decision

After considering all the new evidence and views of topic experts, we decided that this guideline should not be updated.

See how we made the decision for further information.


This page was last updated: